Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FHLC vs. IXJ: which is better?

Bottom line

FHLC vs IXJ: the short answer

FHLC (Fidelity MSCI Health Care Index ETF) and IXJ (iShares Global Healthcare ETF) share a meaningful slice of their top holdings — about 76% by weight.

But FHLC is far broader, holding 337 positions to 124 for IXJ, so beyond the top names it adds exposure IXJ doesn't have.

FHLC is cheaper at 0.084% vs 0.38% — a difference of $30 a year per $10,000 invested.

Over five years, FHLC returned +7.2% a year vs +6.4% for IXJ (reporting dates differ).

Updated Nov 19, 2026

FHLC vs IXJ side by side

FHLCIXJ
TypeETFETF
Fund familyFidelityiShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.084%0.38%
Annual cost per $10k$8.4$38
10-yr cost on $10k (prospectus)$108$480
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+2.6%+14.9%
5-yr return (annualized)+7.2%+6.4%
10-yr return (annualized)+8.8%+8.2%
Best quarter+16.4%+13.6%
Worst quarter−13.1%−11.8%
Net assets (fund)$3.3B$3.8B
Number of holdings337124
Portfolio turnover3%2%
Returns as ofNov 30, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFHLCIXJDifference
2024+2.6%+0.6%+2.0%
2023+2.5%+3.5%−1.0%
2022−5.5%−4.7%−0.8%
2021+20.4%+19.5%+0.9%
2020+18.1%+12.5%+5.6%
2019+21.9%+23.4%−1.4%
2018+5.5%+2.9%+2.7%
2017+23.3%+20.3%+3.0%
2016−3.3%−6.2%+2.9%
2015+7.0%+5.9%+1.1%

Source: Fund prospectus bar charts

Holdings overlap

18 of FHLC's top 25 holdings also appear in IXJ's top 25.

Shared top holdings
HoldingFHLCIXJ
Eli Lilly & Co13.35%10.93%
Johnson & Johnson8.93%7.04%
AbbVie Inc6.42%5.12%
UnitedHealth Group Inc5.44%4.40%
Merck & Co Inc4.66%4.12%
Thermo Fisher Scientific Inc3.09%2.42%
Amgen Inc3.00%2.54%
Abbott Laboratories2.66%2.05%
Gilead Sciences Inc2.34%2.04%
Pfizer Inc2.06%1.78%
Bristol-Myers Squibb Co1.93%1.53%
CVS Health Corp1.92%1.71%
Intuitive Surgical Inc1.82%1.83%
Danaher Corp1.80%1.56%
Vertex Pharmaceuticals Inc1.76%1.64%

Source: SEC Form N-PORT

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

IXJ top 10

  1. Eli Lilly And Company — 10.93%
  2. Johnson & Johnson — 7.04%
  3. Abbvie Inc. — 5.12%
  4. Unitedhealth Group Incorporated — 4.40%
  5. Merck & Co., Inc. — 4.12%
  6. Astrazeneca Plc — 3.76%
  7. Roche Holding AG — 3.75%
  8. Novartis AG — 3.71%
  9. Amgen Inc. — 2.54%
  10. Thermo Fisher Scientific Incorporated — 2.42%

FAQ

What is the difference between FHLC and IXJ?
FHLC (Fidelity MSCI Health Care Index ETF) and IXJ (iShares Global Healthcare ETF) share a meaningful slice of their top holdings — about 76% by weight. But FHLC is far broader, holding 337 positions to 124 for IXJ, so beyond the top names it adds exposure IXJ doesn't have.
Which is cheaper, FHLC or IXJ?
FHLC has the lower expense ratio (0.084%).
Should I own both FHLC and IXJ?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.